Logo image of SGML

SIGMA LITHIUM CORP (SGML) Stock Fundamental Analysis

USA - NASDAQ:SGML - CA8265991023 - Common Stock

7.2 USD
+0.65 (+9.92%)
Last: 9/25/2025, 8:00:02 PM
7.11 USD
-0.09 (-1.25%)
Pre-Market: 9/26/2025, 7:09:43 AM
Fundamental Rating

2

Overall SGML gets a fundamental rating of 2 out of 10. We evaluated SGML against 156 industry peers in the Metals & Mining industry. Both the profitability and financial health of SGML have multiple concerns. SGML is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SGML had negative earnings in the past year.
SGML had a positive operating cash flow in the past year.
In the past 5 years SGML always reported negative net income.
In the past 5 years SGML always reported negative operating cash flow.
SGML Yearly Net Income VS EBIT VS OCF VS FCFSGML Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

SGML has a worse Return On Assets (-17.86%) than 76.92% of its industry peers.
SGML has a Return On Equity of -65.33%. This is amonst the worse of the industry: SGML underperforms 84.62% of its industry peers.
Industry RankSector Rank
ROA -17.86%
ROE -65.33%
ROIC N/A
ROA(3y)-21.3%
ROA(5y)-17.21%
ROE(3y)-46.67%
ROE(5y)-33.09%
ROIC(3y)N/A
ROIC(5y)N/A
SGML Yearly ROA, ROE, ROICSGML Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

1.3 Margins

SGML's Gross Margin of 10.76% is in line compared to the rest of the industry. SGML outperforms 43.59% of its industry peers.
SGML does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGML Yearly Profit, Operating, Gross MarginsSGML Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

0

2. Health

2.1 Basic Checks

SGML does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SGML has more shares outstanding
The number of shares outstanding for SGML has been increased compared to 5 years ago.
The debt/assets ratio for SGML is higher compared to a year ago.
SGML Yearly Shares OutstandingSGML Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SGML Yearly Total Debt VS Total AssetsSGML Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 1.02, we must say that SGML is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.02, SGML is doing worse than 77.56% of the companies in the same industry.
The Debt to FCF ratio of SGML is 18.00, which is on the high side as it means it would take SGML, 18.00 years of fcf income to pay off all of its debts.
SGML's Debt to FCF ratio of 18.00 is in line compared to the rest of the industry. SGML outperforms 58.33% of its industry peers.
A Debt/Equity ratio of 1.26 is on the high side and indicates that SGML has dependencies on debt financing.
With a Debt to Equity ratio value of 1.26, SGML is not doing good in the industry: 87.18% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 18
Altman-Z 1.02
ROIC/WACCN/A
WACC19.99%
SGML Yearly LT Debt VS Equity VS FCFSGML Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

SGML has a Current Ratio of 0.60. This is a bad value and indicates that SGML is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SGML (0.60) is worse than 90.38% of its industry peers.
A Quick Ratio of 0.39 indicates that SGML may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.39, SGML is doing worse than 90.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.39
SGML Yearly Current Assets VS Current LiabilitesSGML Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

The earnings per share for SGML have decreased strongly by -521.77% in the last year.
Looking at the last year, SGML shows a very negative growth in Revenue. The Revenue has decreased by -45.66% in the last year.
EPS 1Y (TTM)-521.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.77%
Revenue 1Y (TTM)-45.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-73.13%

3.2 Future

Based on estimates for the next years, SGML will show a very strong growth in Earnings Per Share. The EPS will grow by 42.82% on average per year.
Based on estimates for the next years, SGML will show a very strong growth in Revenue. The Revenue will grow by 31.94% on average per year.
EPS Next Y127.69%
EPS Next 2Y69.7%
EPS Next 3Y57.05%
EPS Next 5Y42.82%
Revenue Next Year-11%
Revenue Next 2Y11.45%
Revenue Next 3Y32.13%
Revenue Next 5Y31.94%

3.3 Evolution

SGML Yearly Revenue VS EstimatesSGML Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
SGML Yearly EPS VS EstimatesSGML Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

SGML reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 13.20, which indicates a correct valuation of SGML.
71.15% of the companies in the same industry are more expensive than SGML, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.64, SGML is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 13.2
SGML Price Earnings VS Forward Price EarningsSGML Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

63.46% of the companies in the same industry are more expensive than SGML, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 84.02
EV/EBITDA N/A
SGML Per share dataSGML EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

SGML's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SGML's earnings are expected to grow with 57.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y69.7%
EPS Next 3Y57.05%

0

5. Dividend

5.1 Amount

No dividends for SGML!.
Industry RankSector Rank
Dividend Yield N/A

SIGMA LITHIUM CORP

NASDAQ:SGML (9/25/2025, 8:00:02 PM)

Premarket: 7.11 -0.09 (-1.25%)

7.2

+0.65 (+9.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-15 2025-08-15/bmo
Earnings (Next)11-13 2025-11-13/amc
Inst Owners83.28%
Inst Owner Change3.57%
Ins Owners4.56%
Ins Owner ChangeN/A
Market Cap801.43M
Analysts82.86
Price Target12.8 (77.78%)
Short Float %7.29%
Short Ratio2.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)250.01%
Min EPS beat(2)-68.32%
Max EPS beat(2)568.35%
EPS beat(4)1
Avg EPS beat(4)-41.96%
Min EPS beat(4)-424.24%
Max EPS beat(4)568.35%
EPS beat(8)1
Avg EPS beat(8)-82.76%
EPS beat(12)1
Avg EPS beat(12)-239.56%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-22.46%
Min Revenue beat(2)-54.81%
Max Revenue beat(2)9.89%
Revenue beat(4)1
Avg Revenue beat(4)-28.83%
Min Revenue beat(4)-61.22%
Max Revenue beat(4)9.89%
Revenue beat(8)1
Avg Revenue beat(8)-33.91%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.99%
PT rev (3m)26.51%
EPS NQ rev (1m)-56.25%
EPS NQ rev (3m)-57%
EPS NY rev (1m)0%
EPS NY rev (3m)26.88%
Revenue NQ rev (1m)78.96%
Revenue NQ rev (3m)-22.38%
Revenue NY rev (1m)11.09%
Revenue NY rev (3m)-31.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.2
P/S 5.01
P/FCF 84.02
P/OCF 34.29
P/B 8.72
P/tB 8.72
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)0.55
Fwd EY7.57%
FCF(TTM)0.09
FCFY1.19%
OCF(TTM)0.21
OCFY2.92%
SpS1.44
BVpS0.83
TBVpS0.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.86%
ROE -65.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.76%
FCFM 5.96%
ROA(3y)-21.3%
ROA(5y)-17.21%
ROE(3y)-46.67%
ROE(5y)-33.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 18
Debt/EBITDA N/A
Cap/Depr 82.84%
Cap/Sales 8.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.39
Altman-Z 1.02
F-Score2
WACC19.99%
ROIC/WACCN/A
Cap/Depr(3y)42068.9%
Cap/Depr(5y)32157%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-521.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.77%
EPS Next Y127.69%
EPS Next 2Y69.7%
EPS Next 3Y57.05%
EPS Next 5Y42.82%
Revenue 1Y (TTM)-45.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-73.13%
Revenue Next Year-11%
Revenue Next 2Y11.45%
Revenue Next 3Y32.13%
Revenue Next 5Y31.94%
EBIT growth 1Y-141.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year382.75%
EBIT Next 3Y101.58%
EBIT Next 5Y89.98%
FCF growth 1Y104.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y137.39%
OCF growth 3YN/A
OCF growth 5YN/A